Patents Assigned to Phage Biotechnology
-
Patent number: 7435804Abstract: A bacterial high-expression system which is applicable for simultaneous screening of large numbers of recombinant clones from combinatorial antibody libraries is disclosed. The method pertains to screening of single chain antibodies from libraries expressed in the periplasm of E. coli by secretion. By this approach, approximately 104 clones can be screened in a single round. After screening, the clones, which express the recombinant antibodies to the desired antigen, can be directly used for production of large quantities of antibodies from microorganism culture. The system is especially attractive for fast screening of antibody libraries from a hybridoma source. A refolding method for the large-scale production of biologically active scFv-6 his proteins from bacterial inclusion bodies is also disclosed.Type: GrantFiled: October 19, 2004Date of Patent: October 14, 2008Assignee: Phage Biotechnology, Inc.Inventors: Vitaliy A. Kordyum, Oleg Okunev, Pavlo Gilchuk, Olena Deryabina, Dmitro Irodov
-
Publication number: 20080193992Abstract: This invention relates to the use of microorganisms for the generation of ethanol from lignocellulosic waste materials. Yeast strains of the genus Kluyveromyces which have the capability to ferment cellulose, hexose sugars to ethanol are provided. Also provided are methods for converting cellulose, hexoses, or mixed hydrolysates of hexoses to ethanol by fermentation with Kluyveromyces strains. The invention also provides methods to isolate yeast strains which metabolize cellulose, pentoses, or hemicelluloses from waste materials.Type: ApplicationFiled: February 1, 2008Publication date: August 14, 2008Applicant: Phage BiotechnologyInventor: Robert Paul Levine
-
Patent number: 7344876Abstract: This invention relates to the use of microorganisms for the generation of ethanol from lignocellulosic waste materials. Yeast strains of the genus Kluyveromyces which have the capability to ferment cellulose, hexose sugars to ethanol are provided. Also provided are methods for converting cellulose, hexoses, or mixed hydrolysates of hexoses to ethanol by fermentation with Kluyveromyces strains. The invention also provides methods to isolate yeast strains which metabolize cellulose, pentoses, or hemicelluloses from waste materials.Type: GrantFiled: January 16, 2004Date of Patent: March 18, 2008Assignee: Phage Biotechnology, Inc.Inventor: Robert Paul Levine
-
Patent number: 6794162Abstract: This invention relates to a method for enhancing the production of biologically active proteins and peptides in bacterial cells by infecting bacterial cells of the producer strain, which contain a plasmid with one or more targeted genes, with bacteriophage &lgr; with or without the targeted gene(s). The phage increases synthesis of the targeted protein and induces lysis of the producer strain cells. Super-production is achieved by cultivating the producer strain cells under culture conditions that delay lytic development of the phage. The biologically active proteins and peptides subsequently accumulate in a soluble form in the culture medium as the cells of the producer strain are lysed by the phage.Type: GrantFiled: May 17, 2001Date of Patent: September 21, 2004Assignee: Phage Biotechnology CorporationInventors: Vitaliy A. Kordyum, Svitlana I. Chernykh, Iryna Yu Slavchenko, Oleksandr F. Vozlanov
-
Patent number: 6773899Abstract: This invention relates to a method for enhancing the production of biologically active proteins and peptides in bacterial cells by infecting bacterial cells of the producer strain, which contain a plasmid with one or more targeted genes, with bacteriophage &lgr; with or without the targeted gene(s). The targeted genes encoding the biologically active proteins are under the control of a T7 polymerase promoter and the bacteria also are capable of expressing the gene for T7 RNA polymerase. The phage increases synthesis of the targeted protein and induces lysis of the producer strain cells. Super-production is achieved by the combination of the high level of expression achieved from the T7 polymerase promoter and by cultivating the producer strain cells under culture conditions that delay lytic development of the phage. The biologically active proteins and peptides subsequently accumulate in a soluble form in the culture medium as the cells of the producer strain are lysed by the phage.Type: GrantFiled: August 15, 2001Date of Patent: August 10, 2004Assignee: Phage Biotechnology CorporationInventors: Vitaliy A. Kordyum, Iryna Yu. Slavchenko, Svitlana I. Chernykh, Oleksandr F. Vozianov
-
Patent number: 6642026Abstract: The gene of human acidic fibroblast growth factor 155 (haFGF 155) has been obtained by chemical synthesis. The nucleotide sequence of haFGF 155 gene has been deduced on the basis of haFGF 155 amino acid sequence as described in the literature. The amino acid sequence of the synthesized haFGF 155 does not differ from those described in the literature. The nucleotide sequence of haFGF gene differs from those described previously. For chemical synthesis of haFGF 155 gene, codons were used which are the ones most often used by E. coli in highly expressed E. coli proteins. A plasmid with haPGF 155 (phaFGF 155) gene was obtained and was used to transform E. coli. Production of haFGF 154 protein was achieved by cultivation of the producer strain under conditions which slow down the lytic development of lambda phage. The haFGF 154 protein accumulated in culture medium in a soluble condition as a result of the producer strain cells lysis by the lambda phage.Type: GrantFiled: August 15, 2001Date of Patent: November 4, 2003Assignee: Phage Biotechnology CorporationInventors: Thomas J. Stegmann, Vitaliy A. Kordyum, Iryna Yu. Slavchenko, Svitlana I. Chernykh, Oleksandr F. Vozianov
-
Patent number: 6268178Abstract: This invention relates to a method for enhancing the production of biologically active proteins and peptides in bacterial cells by infecting bacterial cells of the producer strain, which contain a plasmid with one or more targeted genes, with bacteriophage &lgr; with or without the targeted gene(s). The phage increases synthesis of the targeted protein and induces lysis of the producer strain cells. Super-production is achieved by cultivating the producer strain cells under culture conditions that delay lytic development of the phage. The biologically active proteins and peptides subsequently accumulate in a soluble form in the culture medium as the cells of the producer strain are lysed by the phage.Type: GrantFiled: May 25, 1999Date of Patent: July 31, 2001Assignee: Phage Biotechnology Corp.Inventors: Vitaliy A. Kordyum, Svetlana I. Chernykh, Irina Y. Slavchenko, Oleksandr F. Vozianov